Related Experiment Videos
Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities
Miroslav Djokic1, Michelle M Le Beau, Lode J Swinnen
1Department of Pathology, University of Chicago Medical Center, 5841 S. Maryland , MC 0008, Illinois 60637, USA.
Genes, Chromosomes & Cancer
|November 12, 2005
Summary
Cytogenetic abnormalities are common in monomorphic post-transplant lymphoproliferative disorders (PTLD), particularly B-cell and T-cell types. Specific chromosomal changes like MYC rearrangement indicate a poor prognosis, while trisomy 9/11 suggests better outcomes in PTLD.
Area of Science:
- Hematology
- Oncology
- Transplant Immunology
Background:
- Cytogenetic analysis has improved understanding of non-Hodgkin lymphoma pathogenesis.
- Limited cytogenetic data exists for post-transplant lymphoproliferative disorder (PTLD).
Purpose of the Study:
- To investigate the cytogenetic landscape of PTLD.
- To correlate chromosomal abnormalities with clinical, laboratory, and pathological findings in PTLD.
Main Methods:
- Karyotype analysis of 36 PTLD cases.
- Classification of PTLD into early lesions, polymorphic PTLD, and monomorphic PTLD (B-cell and T-cell).
- Correlation of cytogenetic findings with clinical outcomes.
Main Results:
- Cytogenetic abnormalities were found in 72% of monomorphic B-cell PTLDs and 100% of T-cell PTLDs.
- Frequent abnormalities included trisomies 9/11, 8q24.1 (MYC), 3q27, and 14q32 rearrangements.
- MYC rearrangement and T-cell abnormalities correlated with poor prognosis.
- Trisomy 9/11 was associated with early post-transplant onset, Epstein-Barr virus-positive large B-cell lymphoma, and prolonged survival.
Conclusions:
- Cytogenetic analysis is crucial for characterizing PTLD subtypes and predicting outcomes.
- Specific chromosomal abnormalities can identify PTLD patients with high-risk or favorable prognoses.
- Further research into the pathogenetic mechanisms underlying these cytogenetic findings is warranted.